U.S., Oct. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07219212) titled 'A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma' on Oct. 17.
Brief Summary: This global, open-label, single arm, phase 1b study aims to learn more about whether a treatment called JNJ-90301900 is safe and effective when injected directly into tumors, along with standard chemotherapy and radiation therapy, for participants with head and neck squamous cell cancer (HNSCC; a type of solid tumor that begins in outer tissue layer of the mouth & throat).
Study Start Date: Jan. 07, 2026
Study Type: INTERVENTIONAL
Condition:
Squamous Cell Carci...